Under the regulation of NOX4, TXNIP may inhibit the activation of NLRP3 inflammatory bodies by dissociating from Trx and binding with NLRP3, and PU may play a meaningful role in protection against diabetic nephropathy. Here, NOX4 is linked to diabetic kidney disease.